0
Article Tier 2 Sign in to save

Micronanoplastic exposure due to cardiopulmonary bypass in children: A prospective observational study.

AI summary Read the abstract

A prospective observational study in children undergoing cardiac surgery with cardiopulmonary bypass (CPB) found measurable levels of micronanoplastics (MNPs) in blood samples collected after bypass. The study demonstrated that CPB circuits made of plastic components release MNPs directly into the bloodstream during surgery.

Cardiopulmonary bypass (CPB) is widely used in cardiac operations. However, it remains unclear whether a CPB circuit, which is mainly made of plastics, can release micronanoplastics (MNPs) into the bloodstream. We conducted a prospective observational study involving children undergoing congenital heart disease repair with CPB support. Blood samples were collected before and after CPB and analyzed using pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS) and laser direct infrared spectroscopy (LDIR) in combination with scanning electron microscopy. A total of 22 patients were involved in this study. The Py-GC/MS analysis revealed a significant increase in total MNPs after CPB support (p < 0.0001). Notably, CPB support significantly increased the levels of polystyrene (p = 0.046), polyethylene (p = 0.038), polypropylene (p < 0.0001), polyvinyl chloride (p < 0.0001), and polyamide 6 (p = 0.027). CPB time was positively correlated to MNP exposure (r = 0.43, p = 0.047). Increases in MNP exposure were positively correlated to an increase in white blood cells (r = 0.52, p = 0.013) and neutrophils (r = 0.46, p = 0.029). The LDIR analysis found that the post-CPB count of MNPs was significantly higher than the pre-CPB count (p = 0.015). In conclusion, CPB support significantly increases exposure to MNP in children undergoing cardiac operations. Further investigations are warranted to clarify the long-term health risks of MNP exposure caused by CPB support.

More Papers Like This

Article Tier 2

Microplastics in cardiopulmonary bypass: quantification and characterization of particles across systems

AI summary Read the abstract

Researchers measured microplastic contamination generated by cardiopulmonary bypass machines used during heart surgery and found significant levels of plastic particles across the systems tested. The study characterized the types and quantities of microplastics produced during machine operation. The findings raise questions about patient exposure to microplastics during cardiac procedures and highlight the need for further research into whether these particles have clinical significance.

Article Tier 2

Microplastic in perfusion: the hidden risk and how to address it

AI summary Read the abstract

This commentary addresses the emerging concern that cardiopulmonary bypass circuits and other extracorporeal circulation systems release significant levels of micro- and nanoplastics into patients during medical procedures. The authors note that the same properties making plastics ideal for medical tubing also make their degradation products potentially harmful. The study calls for further research into the clinical implications of plastic particle exposure during these increasingly common medical interventions.

Article Tier 2

Discovery of microplastics and nanoplastics in pediatric myocardium and blood

AI summary Read the abstract

Researchers detected microplastics and nanoplastics in the heart tissue and blood of 27 pediatric patients undergoing cardiac surgery, with polyethylene found in 100 percent of myocardial samples. Newborns had the highest concentrations of plastic particles in their heart tissue, and matching plastic types were found in mothers' placentas and umbilical cord blood, suggesting prenatal transfer. The study provides the first evidence that micro- and nanoplastics are present in children's cardiac tissue, raising concerns about early-life exposure.

Article Tier 2

Microplastics in cardiopulmonary bypass: quantification and characterisation of particles across systems

AI summary Read the abstract

Researchers quantified microplastics generated during conventional and minimally invasive cardiopulmonary bypass circuits in vitro, finding that both systems shed detectable MPs into circulating fluid, with particle characteristics varying between circuit designs.

Article Tier 2

Polymeric micro- and nanoparticle release from cardiopulmonary bypass and extracorporeal membrane oxygenation circuits.

AI summary Read the abstract

Researchers circulated saline through cardiopulmonary bypass and ECMO circuits for up to seven days and used micro-Raman spectroscopy to identify PVC, PMMA, PET, polyethylene, and polystyrene particles released into the perfusate, finding that particle counts and size range increased progressively over time—raising concern that patients receiving extracorporeal life support are exposed to polymeric microparticles from the circuits themselves.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper